CGPVF(CGPVF)
CGPVF
Q3 2026 EPS Estimate
$-1.81
Jul 30, 2026
Revenue Estimate
$237M
FY2026E EPS$9.94
FY2027E EPS$16.08
Analyst Sentiment
Wall St. Consensus
Buy1 analyst·Low coverage
75
Score
1 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1100%
Hold
00%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
No analyst price targets available for CGPVF
Analyst coverage may not be available for this symbol
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+10.22%
EPS+61.88%
FY2028
Rev+6.60%
EPS+32.46%
FY2029
Rev-1.07%
EPS-30.07%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $1.12B | $1.23B | $1.31B | $1.30B |
| Low | $1.05B | $1.15B | $1.23B | $1.21B |
| High | $1.22B | $1.32B | $1.42B | $1.41B |
| EBITDA Avg | $392M | $432M | $460M | $455M |
| Low | $367M | $403M | $430M | $426M |
| High | $430M | $464M | $499M | $494M |
| EBIT Avg | $163M | $179M | $191M | $189M |
| Low | $153M | $167M | $179M | $177M |
| High | $179M | $193M | $207M | $205M |
| Net Income Avg | $72M | $116M | $154M | $108M |
| Low | $66M | $106M | $141M | $99M |
| High | $80M | $129M | $171M | $120M |
| EPS Avg | $9.94 | $16.08 | $21.31 | $14.90 |
| Low | $9.10 | $14.73 | $19.51 | $13.64 |
| High | $11.04 | $17.87 | $23.68 | $16.56 |
| Analysts (Rev / EPS) | 3 / 1 | 4 / 1 | 2 / 1 | 3 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $276M | $315M |
| Low | $276M | $315M |
| High | $276M | $315M |
| EBITDA Avg | $97M | $111M |
| Low | $97M | $111M |
| High | $97M | $111M |
| EBIT Avg | $40M | $46M |
| Low | $40M | $46M |
| High | $40M | $46M |
| Net Income Avg | $12M | $41M |
| Low | $12M | $41M |
| High | $12M | $41M |
| EPS Avg | $1.67 | $5.68 |
| Low | $1.67 | $5.68 |
| High | $1.67 | $5.68 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
Earnings Surprises
Recent Analyst Actions
No recent analyst actions